Aastrom Biosciences, Inc. (ASTM) Posts Q3 Loss of 6c/Share

November 12, 2013 4:08 PM EST
Aastrom Biosciences, Inc. (NASDAQ: ASTM) reported Q3 EPS of ($0.06), $1.96 better than the analyst estimate of ($2.02).

The substantial decrease in net loss from the prior year is primarily due to decreases in research and development and general and administrative expenses and the non-cash change in the fair value of warrants.

For earnings history and earnings-related data on Aastrom Biosciences, Inc. (ASTM) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment